Skip to main content
Christine E Thatcher on Muck Rack

Christine E Thatcher

As seen in: PLOS, Texas Medical Center
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Christine E

Contact Christine E, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies

|
By Peter R McIlroy, Thomas C. Sheffield, Maxwell A. Stefan, Christine E Thatcher, PLOS Pathogens
| PLOS
Loading metrics Open Access Peer-reviewed Research Article ? This is an uncorrected proof. Citation: McIlroy PR, Pham LTM, Sheffield T, Stefan MA, Thatcher CE, Jaryenneh J, et al. (2025) Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies. PLoS Pathog 21(1): e1012903.
Open in Who Shared Issue with article?

"Therapeutic Efficacy of a Potent Anti-venezuelan Equine Encephalitis V" by Jennifer L Schwedler, Maxwell A Stefan et al.

|
By Jennifer Schwedler, Maxwell A. Stefan, Christine E Thatcher, Peter R McIlroy
| Texas Medical Center
Abstract The development of specific, safe, and potent monoclonal antibodies (Abs) has led to novel therapeutic options for infectious disease. In addition to preventing viral infection through neutralization, Abs can clear infected cells and induce immunomodulatory functions through engagement of their crystallizable fragment (Fc) with complement proteins and Fc receptors on immune cells.
Open in Who Shared Issue with article?
See all 2 articles